Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Veracyte (VCYT) EPS (Weighted Average and Diluted) (2019 - 2026)

Veracyte's EPS (Weighted Average and Diluted) history spans 7 years, with the latest figure at $0.5 for Q4 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) rose 733.33% to $0.5 in Q4 2025 year-over-year; TTM through Dec 2025 was $0.82, a 173.33% increase, with the full-year FY2025 number at $0.82, up 164.52% from a year prior.
  • EPS (Weighted Average and Diluted) hit $0.5 in Q4 2025 for Veracyte, up from $0.24 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for VCYT hit a ceiling of $0.5 in Q4 2025 and a floor of -$0.66 in Q1 2021.
  • Historically, EPS (Weighted Average and Diluted) has averaged -$0.08 across 5 years, with a median of -$0.12 in 2023.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): tumbled 660.0% in 2023 and later soared 733.33% in 2025.
  • Tracing VCYT's EPS (Weighted Average and Diluted) over 5 years: stood at -$0.14 in 2021, then soared by 64.29% to -$0.05 in 2022, then tumbled by 660.0% to -$0.38 in 2023, then soared by 115.79% to $0.06 in 2024, then soared by 733.33% to $0.5 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for VCYT at $0.5 in Q4 2025, $0.24 in Q3 2025, and -$0.01 in Q2 2025.